Quarterly Call Option Transactions in Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX) during . The information is specifically focused on institutions that hold call options of BIOCRYST PHARMACEUTICALS INC.
Calls Purchased
Calls Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q2 2021 | 697,500 | 336,000 | 1,033,500 | 119,600 | 105,000 | 224,600 | 808,900 | |
| Q3 2021 | 764,100 | 455,700 | 1,219,800 | 118,800 | 17,000 | 135,800 | 1,084,000 | |
| Q4 2021 | 274,100 | 19,200 | 293,300 | 594,400 | 522,100 | 1,116,500 | -823,200 | |
| Q1 2022 | 292,400 | 1,852,300 | 2,144,700 | 169,100 | 0 | 169,100 | 1,975,600 | |
| Q2 2022 | 200,000 | 400,000 | 600,000 | 978,600 | 26,400 | 1,005,000 | -405,000 | |
| Q3 2022 | 361,300 | 53,600 | 414,900 | 416,900 | 0 | 416,900 | -2,000 | |
| Q4 2022 | 563,100 | 138,100 | 701,200 | 20,300 | 0 | 20,300 | 680,900 | |
| Q1 2023 | 138,600 | 125,200 | 263,800 | 691,600 | 0 | 691,600 | -427,800 | |
| Q2 2023 | 17,000 | 39,900 | 56,900 | 452,300 | 0 | 452,300 | -395,400 | |
| Q3 2023 | 362,500 | 173,700 | 536,200 | 55,800 | 0 | 55,800 | 480,400 | |
| Q4 2023 | 567,000 | 0 | 567,000 | 227,100 | 0 | 227,100 | 339,900 | |
| Q1 2024 | 0 | 25,000 | 25,000 | 1,410,500 | 0 | 1,410,500 | -1,385,500 | |
| Q2 2024 | 84,600 | 10,000 | 94,600 | 285,200 | 0 | 285,200 | -190,600 | |